Fisher Asset Management
KNSA icon

Fisher Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Fisher Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Sell
398,266
-30,706
-7% -$1.59M 0.01% 319
2026
Q1 		$20.7M Buy
428,972
+161,698
+60% +$7.16M 0.01% 326
2025
Q4 		$11M Sell
267,274
-15,014
-5% -$602K ﹤0.01% 390
2025
Q3 		$11M Buy
282,288
+180,029
+176% +$5.85M ﹤0.01% 393
2025
Q2 		$2.83M Sell
102,259
-41,992
-29% -$1.07M ﹤0.01% 542
2025
Q1 		$3.2M Buy
144,251
+118,127
+452% +$2.43M ﹤0.01% 526
2024
Q4 		$517K Hold
26,124
– – ﹤0.01% 770
2024
Q3 		$653K Sell
26,124
-4,101
-14% -$99.9K ﹤0.01% 718
2024
Q2 		$564K Buy
+30,225
New +$566K ﹤0.01% 767

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Fisher Asset Management's KNSA Position: Q2 2026 in Review

Fisher Asset Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 7.2% in Q2 2026, selling an estimated $1.59M and leaving 398,266 shares worth $25.5M. The position accounts for 0.01% of the portfolio, ranked #319.

Fisher Asset Management first reported a position in KNSA in Q2 2024 and has held it in 9 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Fisher Asset Management held 398,266 shares of Kiniksa Pharmaceuticals worth $25.5M as of Q2 2026.
  • Fisher Asset Management sold 30,706 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $1.59M.
  • Kiniksa Pharmaceuticals made up 0.01% of Fisher Asset Management's portfolio in Q2 2026, its #319 holding.
  • Fisher Asset Management first reported a position in Kiniksa Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.